| Product Code: ETC7188073 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to see significant import shipments of transdermal scopolamine patches, with top exporting countries including Australia, New Zealand, India, Bangladesh, and the USA. Despite the high concentration of the Herfindahl-Hirschman Index (HHI), indicating a competitive market, the compound annual growth rate (CAGR) from 2020 to 2024 remained strong at 6.89%. However, there was a notable decline in growth rate from 2023 to 2024 at -15.21%, suggesting potential shifts in market dynamics or external factors impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Transdermal Scopolamine Patch Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Transdermal Scopolamine Patch Market - Industry Life Cycle |
3.4 Fiji Transdermal Scopolamine Patch Market - Porter's Five Forces |
3.5 Fiji Transdermal Scopolamine Patch Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Fiji Transdermal Scopolamine Patch Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Fiji Transdermal Scopolamine Patch Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Transdermal Scopolamine Patch Market Trends |
6 Fiji Transdermal Scopolamine Patch Market, By Types |
6.1 Fiji Transdermal Scopolamine Patch Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By 1mg, 2021- 2031F |
6.1.4 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By 1.5mg, 2021- 2031F |
6.2 Fiji Transdermal Scopolamine Patch Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By Motion Sickness, 2021- 2031F |
6.2.3 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By Nausea/Vomiting, 2021- 2031F |
6.2.4 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By Parkinsonian Tremor, 2021- 2031F |
6.2.5 Fiji Transdermal Scopolamine Patch Market Revenues & Volume, By Others, 2021- 2031F |
7 Fiji Transdermal Scopolamine Patch Market Import-Export Trade Statistics |
7.1 Fiji Transdermal Scopolamine Patch Market Export to Major Countries |
7.2 Fiji Transdermal Scopolamine Patch Market Imports from Major Countries |
8 Fiji Transdermal Scopolamine Patch Market Key Performance Indicators |
9 Fiji Transdermal Scopolamine Patch Market - Opportunity Assessment |
9.1 Fiji Transdermal Scopolamine Patch Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Fiji Transdermal Scopolamine Patch Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Fiji Transdermal Scopolamine Patch Market - Competitive Landscape |
10.1 Fiji Transdermal Scopolamine Patch Market Revenue Share, By Companies, 2024 |
10.2 Fiji Transdermal Scopolamine Patch Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |